CS
HCAT icon

Credit Suisse’s Health Catalyst HCAT Stock Holding History

Credit Suisse’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$565K Sell
74,987
-152,766
-67% -$1.39M ﹤0.01% 2583
2023
Q4 		$2.11M Sell
227,753
-143,079
-39% -$1.17M ﹤0.01% 1842
2023
Q3 		$3.75M Sell
370,832
-42,297
-10% -$505K ﹤0.01% 1438
2023
Q2 		$5.16M Buy
413,129
+50,280
+14% +$599K 0.01% 1313
2023
Q1 		$4.23M Buy
362,849
+96,333
+36% +$1.23M ﹤0.01% 1424
2022
Q4 		$2.83M Buy
266,516
+497
+0.2% +$4.8K ﹤0.01% 1677
2022
Q3 		$2.58M Sell
266,019
-213,601
-45% -$2.83M ﹤0.01% 1675
2022
Q2 		$6.95M Sell
479,620
-114,205
-19% -$1.95M 0.01% 1105
2022
Q1 		$15.5M Buy
593,825
+153,313
+35% +$4.35M 0.01% 865
2021
Q4 		$17.5M Buy
440,512
+151,587
+52% +$6.91M 0.01% 1155
2021
Q3 		$14.4M Buy
288,925
+55,642
+24% +$3.03M 0.01% 1283
2021
Q2 		$12.9M Sell
233,283
-24,010
-9% -$1.28M 0.01% 1393
2021
Q1 		$12M Sell
257,293
-20,567
-7% -$996K 0.01% 1460
2020
Q4 		$12.1M Sell
277,860
-21,165
-7% -$781K 0.01% 1463
2020
Q3 		$10.9M Sell
299,025
-70,601
-19% -$2.4M 0.01% 1331
2020
Q2 		$10.8M Buy
369,626
+328,562
+800% +$9.08M 0.01% 1255
2020
Q1 		$1.07M Buy
41,064
+13,316
+48% +$407K ﹤0.01% 2605
2019
Q4 		$963K Sell
27,748
-25,780
-48% -$853K ﹤0.01% 3154
2019
Q3 		$1.69M Buy
+53,528
New +$2.11M ﹤0.01% 2605

Other funds holding HCAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse's HCAT Position: Q1 2024 in Review

Credit Suisse reduced its Health Catalyst (HCAT) stake by 67% in Q1 2024, selling an estimated $1.39M and leaving 74,987 shares worth $565K. The position accounts for ﹤0.01% of the portfolio, ranked #2583.

Credit Suisse first reported a position in HCAT in Q3 2019 and has held it in 19 quarters since. The position peaked at $17.5M in Q4 2021. 174 funds tracked by Wall St. Rank hold HCAT as of Q1 2024.

  • Credit Suisse held 74,987 shares of Health Catalyst worth $565K as of Q1 2024.
  • Credit Suisse sold 152,766 Health Catalyst shares in Q1 2024, an estimated $1.39M.
  • Health Catalyst made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2583 holding.
  • Credit Suisse first reported a position in Health Catalyst in Q3 2019 and has held it in 19 quarters since.
  • Credit Suisse's Health Catalyst position peaked at $17.5M in Q4 2021.
  • 174 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.